Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in Cancer Sci Retrieve available abstracts of 48 articles: HTML format Text format

Single Articles

February 2012
1. YAMAMOTO M , Takeuchi K, Shimoji M, Maniwa T, et al
   Small non-mucinous bronchioloalveolar carcinoma (BAC) with ALK immunoreactivity. Immunohistochemistry for ALK showing strong expression in the cytoplasm of small non-mucinous BAC cells.
   Cancer Sci. 2012;103:Febcover.
   PubMed     Text format     Related articles   
   
   
   
   
2. YAMAMOTO M , Takeuchi K, Shimoji M, Maniwa T, et al
   Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: A novel ALK fusion gene?
   Cancer Sci. 2012;103:390-2.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. GRAHAM B , Curry J, Smyth T, Fazal L, et al
   The HSP90 Inhibitor, AT13387, Displays a Long Duration of Action In vitro and In vivo in non-small cell lung cancer.
   Cancer Sci. 2011 Dec 19. doi: 10.1111/j.1349-7006.2011.02191.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. NAGAI H , Ishihara T, Lee WH, Ohara H, et al
   Asbestos surface provides a niche for oxidative modification.
   Cancer Sci. 2011;102:2118-25.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. SIM SH , Ahn YO, Yoon J, Kim TM, et al
   Influence of chemotherapy on iNOS, IDO and CD124 expression in granulocytes and monocytes of non-small cell lung cancer.
   Cancer Sci. 2011 Nov 22. doi: 10.1111/j.1349-7006.2011.02158.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. NAKAZAWA Y , Takagi S, Sato S, Oh-hara T, et al
   Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies.
   Cancer Sci. 2011;102:2051-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
7. SHIRATO H , Onimaru R, Ishikawa M, Kaneko JI, et al
   Real-time Four-dimensional Radiotherapy for Lung Cancer.
   Cancer Sci. 2011 Sep 29. doi: 10.1111/j.1349-7006.2011.02114.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. CHEN MC , Pan SL, Shi Q, Xiao Z, et al
   QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small cell lung cancer (NSCLC) A549 cells.
   Cancer Sci. 2011 Sep 15. doi: 10.1111/j.1349-7006.2011.02103.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KITANO K , Watanabe K, Emoto N, Kage H, et al
   CpG island methylation of microRNAs is associated with tumor size and the recurrence of non-small cell lung cancer.
   Cancer Sci. 2011 Sep 14. doi: 10.1111/j.1349-7006.2011.02101.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LIAO CJ , Wu TI, Huang YH, Chang TC, et al
    Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer.
    Cancer Sci. 2011 Sep 14. doi: 10.1111/j.1349-7006.2011.02102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. SALEEM W , Suzuki Y, Mobaraki A, Yoshida Y, et al
    Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non-small cell lung cancer.
    Cancer Sci. 2011 Sep 7. doi: 10.1111/j.1349-7006.2011.02095.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. YAMADA T , Bando H, Takeuchi S, Kita K, et al
    Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small cell lung cancer cells.
    Cancer Sci. 2011 Sep 5. doi: 10.1111/j.1349-7006.2011.02093.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
13. FUJIE H , Tanaka T, Tagawa M, Kaijun N, et al
    Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer.
    Cancer Sci. 2011 Aug 24. doi: 10.1111/j.1349-7006.2011.02079.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KIJIMA T , Takeuchi K, Tetsumoto S, Shimada K, et al
    Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.
    Cancer Sci. 2011;102:1602-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CHEN CY , Fang HY, Chiou SH, Yi SE, et al
    Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells.
    Cancer Sci. 2011;102:1582-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
16. LEE MW , Kim DS, Lee JH, Lee BS, et al
    The roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth and migration.
    Cancer Sci. 2011 Jul 2. doi: 10.1111/j.1349-7006.2011.02025.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. ZHOU X , Li X, Gou M, Qiu J, et al
    Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
    Cancer Sci. 2011;102:1403-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. TAKAWA M , Masuda K, Kunizaki M, Daigo Y, et al
    Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker.
    Cancer Sci. 2011;102:1298-305.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
19. HASE T , Sato M, Yoshida K, Girard L, et al
    A Pivotal Role for Epithelial Cell Adhesion Molecule (EpCAM) in the Survival of Lung Cancer Cells.
    Cancer Sci. 2011 May 2. doi: 10.1111/j.1349-7006.2011.01973.
    PubMed     Text format     Related articles   
    
    
    
    
20. SATOH N , Maniwa Y, Bermudez VP, Nishimura K, et al
    Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
    Cancer Sci. 2011;102:1101-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
21. OHARA T , Takaoka M, Toyooka S, Tomono Y, et al
    Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small cell lung cancer cells.
    Cancer Sci. 2011 Apr 26. doi: 10.1111/j.1349-7006.2011.01967.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
22. ZHANG G , Ding L, Renegar R, Wang XM, et al
    Hydroxycamptothecin-Loaded Fe(3) O(4) Nanoparticles Induce Human Lung Cancer Cell Apoptosis through Caspase-8 Pathway Activation and Disrupt Tight Junctions.
    Cancer Sci. 2011 Mar 25. doi: 10.1111/j.1349-7006.2011.01930.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
23. IZUMI H , Takahashi M, Uramoto H, Nakayama Y, et al
    The monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
    Cancer Sci. 2011 Feb 9. doi: 10.1111/j.1349-7006.2011.01908.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. FUKUSHIMA T , Kawaguchi M, Yamasaki M, Tanaka H, et al
    Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.
    Cancer Sci. 2011;102:407-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
25. KIMURA M , Takenobu H, Akita N, Nakazawa A, et al
    Bmi1 regulates cell fate via tumor suppressor WWOX repression in small cell lung cancer cells.
    Cancer Sci. 2011 Jan 28. doi: 10.1111/j.1349-7006.2011.01891.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SHUKUYA T , Takahashi T, Kaira R, Ono A, et al
    The efficacy of gefitinib for non-adeno non-small-cell lung cancer patients harboring EGFR mutations: A pooled analysis of published reports.
    Cancer Sci. 2011 Jan 27. doi: 10.1111/j.1349-7006.2011.01887.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TOMITA Y , Harao M, Senju S, Imai K, et al
    Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells.
    Cancer Sci. 2011;102:71-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. CHANG YL , Wu CT, Shih JY, Lee YC, et al
    Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas.
    Cancer Sci. 2011;102:282-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
29. HIDA T , Tamiya M, Nishio M, Yamamoto N, et al
    A Phase I Study of Intravenous ASA404 (vadimezan) Administered in Combination with Paclitaxel and Carboplatin in Japanese Patients with Non-small Cell Lung Cancer.
    Cancer Sci. 2010 Dec 23. doi: 10.1111/j.1349-7006.2010.01839.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. WANG HM , Cheng KC, Lin CJ, Hsu SW, et al
    Obtusilactone A and (-)-sesamin induce apoptosis in human lung cancer cells by inhibiting mitochondrial Lon protease and activating DNA damage checkpoints.
    Cancer Sci. 2010;101:2612-2620.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
31. DAI SD , Wang Y, Zhang JY, Zhang D, et al
    Upregulation of delta-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer.
    Cancer Sci. 2010 Nov 10. doi: 10.1111/j.1349-7006.2010.01766.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. WEN Y , Wang CT, Ma TT, Li ZY, et al
    Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model.
    Cancer Sci. 2010;101:2325-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. HO MY , Tang SJ, Ng WV, Yang W, et al
    Nucleotide-binding domain of phosphoglycerate kinase 1 reduces tumor growth by suppressing COX-2 expression.
    Cancer Sci. 2010;101:2411-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
34. JIN G , Yoo SS, Cho S, Jeon HS, et al
    Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer.
    Cancer Sci. 2010 Oct 26. doi: 10.1111/j.1349-7006.2010.01782.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. PITCHAKARN P , Ogawa K, Suzuki S, Takahashi S, et al
    Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo.
    Cancer Sci. 2010;101:2234-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
36. CHEN X , Xie Q, Cheng X, Diao X, et al
    Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
    Cancer Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
37. ZHANG Y , Song H, Miao Y, Wang R, et al
    Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
    Cancer Sci. 2010 Aug 19. doi: 10.1111/j.1349-7006.2009.01486.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. OSADA H , Takahashi T
    let-7 and miR-17-92: Small-sized major players in lung cancer development.
    Cancer Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. IWAKAWA R , Kohno T, Enari M, Kiyono T, et al
    Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma.
    Cancer Sci. 2010;101:1891-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
40. OKITA K , Motohashi S, Shinnakasu R, Nagato K, et al
    A set of genes associated with the interferon-gamma response of lung cancer patients undergoing alpha-galactosylceramide-pulsed dendritic cell therapy.
    Cancer Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. UEMURA T , Oguri T, Ozasa H, Takakuwa O, et al
    ABCC11/MRP8 confers pemetrexed resistance in lung cancer.
    Cancer Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KIM M , Kang HG, Lee SY, Lee HC, et al
    Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.
    Cancer Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. OKADA A , Shimmyo T, Hashimoto T, Kobayashi Y, et al
    Predictive advantage of a cell type classification for pulmonary adenocarcinoma coupled with data for p53, K-ras and EGFR alterations.
    Cancer Sci. 2010;101:1745-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. TAURA M , Fukuda R, Suico MA, Eguma A, et al
    TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis.
    Cancer Sci. 2010;101:1610-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
45. BABA T , Hanagiri T, Takenoyama M, Shiota H, et al
    Identification of a lung cancer antigen evading CTL attack due to loss of human leukocyte antigen (HLA) class I expression.
    Cancer Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
46. SUN H , Qiao Y, Zhang X, Xu L, et al
    XRCC3 Thr241Met polymorphism with lung caner and bladder cancer: A meta-analysis.
    Cancer Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. PAUDYAL P , Paudyal B, Hanaoka H, Oriuchi N, et al
    Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET.
    Cancer Sci. 2010;101:1045-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. FUKAMI T , Nakajima M, Matsumoto I, Zen Y, et al
    Immunohistochemical analysis of CYP2A13 in various types of human lung cancers.
    Cancer Sci. 2010;101:1024-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: